New inhibitors of catalytic subunit of telomerase.

2014/13/B/NZ7/02207

Keywords

Descriptors

  • NZ7_14: Farmacja, farmakoterapia, farmakologia
  • ST5_20: Chemia pojedynczych cząsteczek i makrocząsteczek
  • NZ2_10: Modelowanie i symulacje biologiczne

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Politechnika Gdańska, Wydział Chemiczny

Voivodeship: pomorskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

prof. Maciej Bagiński

Number of co-investigators in the project: 7

Call

OPUS 7 – announced on 2014-03-17

Amount awarded
529 720 PLN
Project start date
2015-01-28
Project end date
2019-07-27
Project duration
54 months (the same as in the proposal)
Project status
Project settled

Equipment purchased [PL]

  1. Komputer PC. Cost: 8 000 PLN
  2. System do dokunentacji żeli. Cost: 35 000 PLN

Information in the final report

Publication in academic press/journals (1)

  1. Structural, functional, and stability change predictions in human telomerase upon specific point mutations

    Authors:
    U. Kalathiya, M. Padariya, M. Baginski
    Academic press:
    Scientific Reports (year: 2019, volume: 6,42152777777778, pages: 46035), Publisher: Nature Publishing group
    Status:
    Published
    DOI:
    10.1038/s41598-019-45206-y – link to the publication

Articles in post-conference publications (3)

  1. Structural analysis and predicting effects of natural mutations on telomerase.

    Authors:
    M. Padariya, U. Kalathiya, and M. Baginski
    Conference:
    24th Congress & General Assembly of the International Union of Crystallography 2017, Hyderabad, India (year: 2017, pages: Book of abstracts poster 2059), Publisher: International Union of Crystallography
    Date:
    conference 42948
    Status:
    Published
  2. Molecular modeling and evaluation of dibenzopyrrole derivatives towards telomerase.

    Authors:
    M. Padariya, U. Kalathiya, M. Baginski
    Conference:
    EMBO Conference: Towards Novel Therapies: Emerging Insights from Structural and Molecular Biology, Groningen, The Netherlands (year: 2017, pages: Book of abstracts poster 32), Publisher: EMBO, University of Groningen, The Netherlands
    Date:
    conference 42795
    Status:
    Published
  3. Novel telomerase inhibitors for cancer therapy - in silico design and biological evaluation

    Authors:
    M. Padariya, U. Kalathiya, M. Wysocka, K. Szwarc, M. Serocki, A. Skladanowski, M. Baginski
    Conference:
    2015 International Chemical Congress of Pacific Basin Societies (year: 2015, pages: 294-TECH, Abstract 449), Publisher: PacifiChem
    Date:
    conference 15-20 grudzień 2015
    Status:
    Published
    DOI:
    link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski